Answer
Feb 02, 2026 - 01:09 PM
Do you have the same question? Follow this Question
Feb 02, 2026 - 01:09 PM
We’ve provided several answers to questions related to Taltz (Ixekizumab) , see some other helpful Q&A related to this product.
Question: Where can I inject this medication?
Answer: Common injection sites include the front of the thighs, the lower abdomen (avoiding the area around the belly button), and the outer area of the upper arm. Rotating injection sites can help minimize irritation and maximize comfort.
Question: What is the primary use of this medication?
Answer: The medication is primarily used to treat autoimmune diseases, including plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis. Treating these conditions can significantly improve quality of life by reducing inflammation and related symptoms.
Question: What is the KEGG code for this medication?
Answer: The KEGG code is D10071. KEGG codes are used in biological databases to track drugs and their effects, supporting research and healthcare data management.
Question: What are the main inactive ingredients in this medication?
Answer: Inactive ingredients may include polysorbate 80, sucrose, and sodium hydroxide. These ingredients help stabilize the formulation and maintain the medication's effectiveness and safety.
Question: What are the routes of administration for this medication?
Answer: The medication is administered via subcutaneous injection. Subcutaneous injections are given under the skin, which can be easier and less invasive than intravenous routes, making self-administration possible.
Question: What is the strength or dosage of this medication?
Answer: The strength is 80mg per milliliter (80mg/mL). This standardized dosage helps ensure consistent and effective treatment.
Question: What is the active ingredient in this medication?
Answer: The active ingredient is Ixekizumab, which is a humanized immunoglobulin G subclass 4 (IgG4) monoclonal antibody. IgG4 is a type of antibody that helps the immune system target specific proteins, providing targeted treatment for autoimmune diseases.